Annual Cash & Cash Equivalents
$33.51 M
+$8.33 M+33.10%
December 31, 2023
Summary
- As of February 26, 2025, GYRE annual cash & cash equivalents is $33.51 million, with the most recent change of +$8.33 million (+33.10%) on December 31, 2023.
- During the last 3 years, GYRE annual cash & cash equivalents has risen by +$7.42 million (+28.44%).
- GYRE annual cash & cash equivalents is now at all-time high.
Performance
GYRE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$15.87 M
-$231.00 K-1.44%
September 30, 2024
Summary
- As of February 26, 2025, GYRE quarterly cash and cash equivalents is $15.87 million, with the most recent change of -$231.00 thousand (-1.44%) on September 30, 2024.
- Over the past year, GYRE quarterly cash and cash equivalents has dropped by -$17.64 million (-52.65%).
- GYRE quarterly cash and cash equivalents is now -52.65% below its all-time high of $33.51 million, reached on December 31, 2023.
Performance
GYRE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GYRE Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.1% | -52.6% |
| 3 y3 years | +28.4% | -40.0% |
| 5 y5 years | +28.4% | -40.0% |
GYRE Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +33.1% | -52.6% | at low |
| 5 y | 5-year | at high | +33.1% | -52.6% | at low |
| alltime | all time | at high | +33.1% | -52.6% | at low |
Gyre Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.87 M(-1.4%) |
| Jun 2024 | - | $16.10 M(-46.0%) |
| Mar 2024 | - | $29.79 M(-11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $33.51 M(+33.1%) | $33.51 M(+26.8%) |
| Mar 2023 | - | $26.42 M |
| Dec 2022 | $25.18 M(-3.5%) | - |
| Dec 2021 | $26.09 M | - |
FAQ
- What is Gyre Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Gyre Therapeutics?
- What is Gyre Therapeutics annual cash & cash equivalents year-on-year change?
- What is Gyre Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Gyre Therapeutics?
- What is Gyre Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Gyre Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of GYRE is $33.51 M
What is the all time high annual cash & cash equivalents for Gyre Therapeutics?
Gyre Therapeutics all-time high annual cash & cash equivalents is $33.51 M
What is Gyre Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, GYRE annual cash & cash equivalents has changed by +$8.33 M (+33.10%)
What is Gyre Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GYRE is $15.87 M
What is the all time high quarterly cash and cash equivalents for Gyre Therapeutics?
Gyre Therapeutics all-time high quarterly cash and cash equivalents is $33.51 M
What is Gyre Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, GYRE quarterly cash and cash equivalents has changed by -$17.64 M (-52.65%)